Table I.

Previously reported cases of squamous cell carcinoma associated with OGCs in the uterine cervix.

Case	Author (ref.)	Age, years	Tumor diameter, cm	Tumor stage	Clinical manifestation	Growth pattern	Histological type of SCC	Immumohistochemical staining of OGC	Treatment	Follow-up/Status
1	Pang (7)	65	6	Ib	IVB	Polypoid mass	Sarcomatoid type	Positive for Kp1 and CD68; negative for CK and vimentin	Hysterectomy and lymphadenectomy; radiotherapy and chemotherapy	7 weeks, DOD
2	Pang (7)	61	5	Ib	IVB	Polypoid mass	Sarcomatoid type	Positive for Kp1 and CD68; negative for CK and vimentin	Hysterectomy and lymphadenectomy; radiotherapy and chemotherapy	14 months, DOD
3	Singh et al (8)	60	4.5	Ib	IVB	Infiltrated mass	NK type	Positive for CD68; negative for CK, EMA and vimentin	Radiotherapy and chemotherapy	6 months, ACR
4	Present case	84	5	Ib	IVB	Polypoid mass	NK type	Positive for CD68 and vimentin; negative for CK	Radiotherapy	8 months, DOD

Tumor stage was diagnosed in accordance with the International Federation of Gynecology and Obstetrics staging for staging for carcinoma of the vulva, cervix, and endometrium (2009) (12). OGCs, osteoclast-like giant cells; IVB, irregular vaginal bleeding; SCC, squamous cell carcinoma; NK, non-keratinizing; DOD, dead of disease; ACR, alive with complete regression of the growth.